Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2013
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer | 01/11/2013 | INTERVENTIONAL | unchanged | 4,975.85 | 0 |
|---|
| Group Interventions for Breast Cancer Survivors | 01/24/2013 | INTERVENTIONAL | unchanged | 4,962.85 | 0 |
|---|
| Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening | 02/04/2013 | INTERVENTIONAL | unchanged | 4,951.85 | 0 |
|---|
| Pre Operative Trastuzumab in Operable Breast Cancer | 02/07/2013 | INTERVENTIONAL | unchanged | 4,948.85 | 0 |
|---|
| Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma | 02/11/2013 | OBSERVATIONAL | unchanged | 4,944.85 | 0 |
|---|
| A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer | 02/15/2013 | OBSERVATIONAL | unchanged | 4,940.85 | 0 |
|---|
| OTIS Cimzia Pregnancy Registry | 02/22/2013 | OBSERVATIONAL | unchanged | 4,933.85 | 0 |
|---|
| Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | 02/26/2013 | INTERVENTIONAL | unchanged | 4,929.85 | 0 |
|---|
| Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy | 03/06/2013 | INTERVENTIONAL | unchanged | 4,921.85 | 0 |
|---|
| Reproductive Health Program in Patients With Cancer | 03/07/2013 | INTERVENTIONAL | unchanged | 4,920.85 | 0 |
|---|
| Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study | 03/22/2013 | OBSERVATIONAL | unchanged | 4,905.85 | 0 |
|---|
| The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma | 03/29/2013 | INTERVENTIONAL | unchanged | 4,898.85 | 0 |
|---|
| The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma | 03/29/2013 | INTERVENTIONAL | unchanged | 4,898.85 | 0 |
|---|
| Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors | 04/05/2013 | INTERVENTIONAL | unchanged | 4,891.85 | 0 |
|---|
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | 04/05/2013 | INTERVENTIONAL | unchanged | 4,891.85 | 0 |
|---|
| Prospective Data Bank Creation to Study Vaginal Conditions | 04/11/2013 | OBSERVATIONAL | unchanged | 4,885.85 | 0 |
|---|
| Breast Cancer Proteomics and Molecular Heterogeneity | 04/25/2013 | OBSERVATIONAL | unchanged | 4,871.85 | 0 |
|---|
| Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry | 04/30/2013 | OBSERVATIONAL | unchanged | 4,866.85 | 0 |
|---|
| Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. | 05/03/2013 | INTERVENTIONAL | unchanged | 4,863.85 | 0 |
|---|
| Ovarian Tissue Transplantation | 06/06/2013 | INTERVENTIONAL | unchanged | 4,829.85 | 0 |
|---|
| Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer | 06/07/2013 | INTERVENTIONAL | unchanged | 4,828.85 | 0 |
|---|
| Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery | 06/07/2013 | INTERVENTIONAL | unchanged | 4,828.85 | 0 |
|---|
| Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy | 06/11/2013 | INTERVENTIONAL | unchanged | 4,824.85 | 0 |
|---|
| An Optimized Programming of Healthy Children (APPROACH) | 07/10/2013 | INTERVENTIONAL | unchanged | 4,795.85 | 0 |
|---|
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | 07/23/2013 | INTERVENTIONAL | unchanged | 4,782.85 | 0 |
|---|
| Prophylactic Salpingectomy With Delayed Oophorectomy | 07/25/2013 | INTERVENTIONAL | unchanged | 4,780.85 | 0 |
|---|
| Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer | 08/05/2013 | INTERVENTIONAL | unchanged | 4,769.85 | 0 |
|---|
| Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer | 08/26/2013 | INTERVENTIONAL | unchanged | 4,748.85 | 0 |
|---|
| Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer | 09/17/2013 | INTERVENTIONAL | unchanged | 4,726.85 | 0 |
|---|
| Endometriosis, Food Consumption and Fertility | 09/20/2013 | OBSERVATIONAL | unchanged | 4,723.85 | 0 |
|---|
| Assessment of Paclitaxel-Induced Neuropathy | 09/30/2013 | OBSERVATIONAL | unchanged | 4,713.85 | 0 |
|---|
| Muscle Fiber Fragment Treatment for Urinary Incontinence | 09/30/2013 | INTERVENTIONAL | unchanged | 4,713.85 | 0 |
|---|
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery | 10/01/2013 | INTERVENTIONAL | unchanged | 4,712.85 | 0 |
|---|
| SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy | 10/22/2013 | OBSERVATIONAL | unchanged | 4,691.85 | 0 |
|---|
| Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer | 10/28/2013 | INTERVENTIONAL | unchanged | 4,685.85 | 0 |
|---|
| A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction | 11/05/2013 | INTERVENTIONAL | unchanged | 4,677.85 | 0 |
|---|
| Predictive Clinical and Biological Parameters in Gynecological Cancer | 11/06/2013 | INTERVENTIONAL | unchanged | 4,676.85 | 0 |
|---|
| REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy | 11/14/2013 | INTERVENTIONAL | unchanged | 4,668.85 | 0 |
|---|
| Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) | 11/25/2013 | OBSERVATIONAL | unchanged | 4,657.85 | 0 |
|---|
| Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer | 11/25/2013 | INTERVENTIONAL | unchanged | 4,657.85 | 0 |
|---|
| Chronic Toxicities Related to Treatment in Patients With Localized Cancer | 11/25/2013 | INTERVENTIONAL | unchanged | 4,657.85 | 0 |
|---|
| FDG PET/CT in Breast Cancer Bone Mets | 11/27/2013 | OBSERVATIONAL | unchanged | 4,655.85 | 0 |
|---|
| Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine | 12/09/2013 | INTERVENTIONAL | unchanged | 4,643.85 | 0 |
|---|
| Characterization of a Prospective Cohort of Women With PCOS | 12/13/2013 | OBSERVATIONAL | unchanged | 4,639.85 | 0 |
|---|